1、eBookPowered byThe next wave in oncologyJames DrewSenior Manager,Content Strategy|CitelineMattew CunninghamPartner|The Dedham GroupDana GheorgheTherapy Area Director of Oncology|C|2024 NorstellaIzabela ChmielewskaManaging Editor,Custom Content|NorstellaAuthor7 innovations redefining oncology in 2024

2、 and beyondThe oncology field is in a transformative era,driven by a continuous innovation cycle.Breakthrough therapies and cutting-edge technologies are setting new standards in cancer treatment,enhancing patient outcomes and pushing the boundaries of medical science.However,this dynamic landscape

3、is not without its challenges,including managing evolving patient needs and integrating new treatments into existing healthcare frameworks.As we move through 2024,it is critical for life sciences professionals to stay informed about these rapid advancements.Leveraging recent insights from Norstellas

4、 experts,along with ongoing market opinions and trends,this ebook highlights the current developments and future predictions shaping the field of oncology.Mary Jo LafflerExecutive Editor,US Commercial/R&D|ScripContributorsContentThe rise of antibody-drug conjugatesNext-generation CAR T-cell therapie

5、sDigitization&decentralization of clinical trialsThe emerging role of AI in oncologyAdvancements in immuno-oncologyInnovations in cancer screening and early detectionAdvances in cancer survival |2024 Norstella1The rise of antibody-drug conjugatesAntibody-drug conjugates(ADCs)are revolutionizing targ

6、eted cancer therapy by combining the precision of monoclonal antibodies with the potent cell-killing ability of cytotoxic drugs.Designed to selectively target cancer cells while sparing healthy tissue,ADCs are expected to drive significant market growth,with sales projected to steeply increase by 20